Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
Nat Commun. 2022 Apr 11;13(1):1981. doi: 10.1038/s41467-022-29173-z.
T cell large granular lymphocytic leukemia (T-LGLL) is a rare lymphoproliferative disorder of mature, clonally expanded T cells, where somatic-activating STAT3 mutations are common. Although T-LGLL has been described as a chronic T cell response to an antigen, the function of the non-leukemic immune system in this response is largely uncharacterized. Here, by utilizing single-cell RNA and T cell receptor profiling (scRNA+TCRαβ-seq), we show that irrespective of STAT3 mutation status, T-LGLL clonotypes are more cytotoxic and exhausted than healthy reactive clonotypes. In addition, T-LGLL clonotypes show more active cell communication than reactive clones with non-leukemic immune cells via costimulatory cell-cell interactions, monocyte-secreted proinflammatory cytokines, and T-LGLL-clone-secreted IFNγ. Besides the leukemic repertoire, the non-leukemic T cell repertoire in T-LGLL is also more mature, cytotoxic, and clonally restricted than in other cancers and autoimmune disorders. Finally, 72% of the leukemic T-LGLL clonotypes share T cell receptor similarities with their non-leukemic repertoire, linking the leukemic and non-leukemic repertoires together via possible common target antigens. Our results provide a rationale to prioritize therapies that target the entire immune repertoire and not only the T-LGLL clonotype.
T 细胞大颗粒淋巴细胞白血病(T-LGLL)是一种罕见的成熟克隆性扩展 T 细胞的淋巴增殖性疾病,体细胞激活的 STAT3 突变很常见。尽管 T-LGLL 已被描述为对抗原的慢性 T 细胞反应,但该反应中非白血病免疫细胞的功能在很大程度上尚未确定。在这里,我们通过利用单细胞 RNA 和 T 细胞受体谱(scRNA+TCRαβ-seq)分析,表明无论 STAT3 突变状态如何,T-LGLL 克隆型比健康反应性克隆型更具细胞毒性和耗竭性。此外,T-LGLL 克隆型通过共刺激细胞-细胞相互作用、单核细胞分泌的促炎细胞因子和 T-LGLL 克隆分泌的 IFNγ 与非白血病免疫细胞表现出更活跃的细胞通讯。除了白血病谱外,T-LGLL 中的非白血病 T 细胞谱也比其他癌症和自身免疫性疾病更成熟、更具细胞毒性和克隆受限。最后,72%的白血病 T-LGLL 克隆型与非白血病 T 细胞库具有 T 细胞受体相似性,通过可能的共同靶抗原将白血病和非白血病库联系在一起。我们的研究结果为优先考虑靶向整个免疫库而不仅仅是 T-LGLL 克隆型的治疗方法提供了依据。